The FDA issued an emergency use authorization (EUA) for pemivibart (Pemgarda) as COVID-19 pre-exposure prophylaxis in immunocompromised individuals who are unlikely to mount a sufficient immune ...
Dr. Caroline Wilker of Mayo La Crosse, a coauthor of the study and SW Wisconsin physician lead for the COVID frontline care team, says across the Mayo enterprise, which includes Florida, Arizona, ...
On March 22, the U.S. Food and Drug Administration, or FDA, issued an emergency use authorization for Pemgarda — a new drug that prevents COVID-19 infection — for certain adults and adolescents, ...
How Does Sarclisa Work in Multiple Myeloma? Sarclisa is a type of medicine called a monoclonal antibody that is also known as a targeted therapy or an immunotherapy. It works by targeting a specific ...
There are a variety of therapies available compared to early in the pandemic. It's hard to imagine a time when treatments weren't available for COVID-19. Yet this was the case when the World Health ...
Monoclonal antibodies are among our greatest assets in treating and preventing virus-induced disease. While the spotlight has focused squarely on Covid-19 monoclonal antibodies throughout the pandemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback